Solved

The Labeling for Clopidogrel Discusses Pharmacogenomic Testing for Genetic Variation

Question 5

Multiple Choice

The labeling for clopidogrel discusses pharmacogenomic testing for genetic variation in which of the following?


A) CYP2C19
B) HLA-B*5701
C) CYP2D6
D) UGT1A1

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions